Combinatorial Haplo-deficient tumor suppression in 7q-Deficient myelodysplastic syndrome and acute myeloid leukemia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Heterozygous deletions of chromosome 7 are frequent in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this issue of Cancer Cell, Chen and colleagues identify MLL3 as a novel haplo-insufficient tumor suppressor on 7q that, in combination with NF1 suppression and TP53 deficiency, mediates MDS and AML phenotypes in mouse and human systems.

Original languageEnglish (US)
Pages (from-to)555-557
Number of pages3
JournalCancer Cell
Volume25
Issue number5
DOIs
StatePublished - May 12 2014

Fingerprint

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Chromosomes, Human, Pair 7
Neoplasms
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

@article{674ad89bbf8446ada30855a3604f9cad,
title = "Combinatorial Haplo-deficient tumor suppression in 7q-Deficient myelodysplastic syndrome and acute myeloid leukemia",
abstract = "Heterozygous deletions of chromosome 7 are frequent in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this issue of Cancer Cell, Chen and colleagues identify MLL3 as a novel haplo-insufficient tumor suppressor on 7q that, in combination with NF1 suppression and TP53 deficiency, mediates MDS and AML phenotypes in mouse and human systems.",
author = "Britta Will and Steidl, {Ulrich G.}",
year = "2014",
month = "5",
day = "12",
doi = "10.1016/j.ccr.2014.04.018",
language = "English (US)",
volume = "25",
pages = "555--557",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Combinatorial Haplo-deficient tumor suppression in 7q-Deficient myelodysplastic syndrome and acute myeloid leukemia

AU - Will, Britta

AU - Steidl, Ulrich G.

PY - 2014/5/12

Y1 - 2014/5/12

N2 - Heterozygous deletions of chromosome 7 are frequent in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this issue of Cancer Cell, Chen and colleagues identify MLL3 as a novel haplo-insufficient tumor suppressor on 7q that, in combination with NF1 suppression and TP53 deficiency, mediates MDS and AML phenotypes in mouse and human systems.

AB - Heterozygous deletions of chromosome 7 are frequent in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this issue of Cancer Cell, Chen and colleagues identify MLL3 as a novel haplo-insufficient tumor suppressor on 7q that, in combination with NF1 suppression and TP53 deficiency, mediates MDS and AML phenotypes in mouse and human systems.

UR - http://www.scopus.com/inward/record.url?scp=84900315120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900315120&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2014.04.018

DO - 10.1016/j.ccr.2014.04.018

M3 - Article

C2 - 24823633

AN - SCOPUS:84900315120

VL - 25

SP - 555

EP - 557

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -